Headquarters: People's Republic of China

MBMbio

My-BioMed Biotechnology (MBM) was founded in 2016. MBM business covers precision medicine; artificial intelligence and digital pathology, cancer early detection, diagnostic and prognostic biomarkers, as well as in other diseases. MBM is committed to bridging world innovations in precision medicine. It is a precision medicine platform in China aimed at the transformation and commercialization of diagnostics and medical artificial intelligence technologies. MBM introduces technologies and products that are clinically proven, with a focus on oncology and cardiovascular.

Visit the MBMbio website

Related Platforms

Shaping the Future of Health and Healthcare

Transforming the healthcare industry while promoting healthy lives and ensuring access to affordable quality care for all.Global healthcare spending is projected to increase from $7.7 tri...